, IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, vol.100, pp.1-487

W. J. Edmunds, G. F. Medley, D. J. Nokes, A. J. Hall, and H. C. Whittle, The influence of age on the development of the hepatitis B carrier state, Proc Biol Sci, vol.253, pp.197-201, 1993.

B. Larouze, G. Saimot, E. D. Lustbader, W. T. London, B. G. Werner et al., Host responses to hepatitis-B infection in patients with primary hepatic carcinoma and their families. A case/control study in Senegal, Lancet, vol.2, pp.534-538, 1976.

Y. R. Tseng, J. F. Wu, Y. H. Ni, H. L. Chen, C. C. Chen et al., Long-term effect of maternal HBeAg on delayed HBeAg seroconversion in offspring with chronic hepatitis B infection, Liver Int, vol.31, pp.1373-1380, 2011.

S. J. Hadziyannis, Natural history of chronic hepatitis B in Euro-Mediterranean and African countries, J Hepatol, vol.55, pp.183-191, 2011.

Y. Shimakawa, H. Yan, N. Tsuchiya, C. Bottomley, and A. J. Hall, Association of early age at establishment of chronic hepatitis B infection with persistent viral replication, liver cirrhosis and hepatocellular carcinoma: a systematic review, PLoS One, vol.8, p.69430, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-02875324

W. J. Edmunds, G. F. Medley, D. J. Nokes, C. J. O'callaghan, H. C. Whittle et al., Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas, Epidemiol Infect, vol.117, pp.313-325, 1996.

H. C. Whittle, A. K. Bradley, and K. Mclauchlan, Hepatitis B virus infection in two Gambian villages, Lancet, vol.1, pp.1203-1206, 1983.

H. Whittle, H. Inskip, A. K. Bradley, K. Mclaughlan, F. Shenton et al., The Pattern of Childhood Hepatitis B Infection in Two Gambian Villages, J Infect Dis, vol.161, pp.1112-1115, 1990.

, The Gambia Hepatitis Study Group: The Gambia hepatitis intervention study, Cancer Res, vol.47, pp.5782-5787, 1987.

M. Vall-mayans, A. Hall, H. Inskip, J. Chotard, S. Lindsay et al., Risk factors for transmission of hepatitis B virus to Gambian children, Lancet, vol.336, pp.1107-1109, 1990.

S. Greenland, J. Pearl, and J. M. Robins, Causal diagrams for epidemiologic research, Epidemiol, vol.10, pp.37-48, 1999.

H. C. Whittle, H. Inskip, A. J. Hall, M. Mendy, R. Downes et al., Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia, Lancet, vol.337, pp.747-750, 1991.

F. Barin, J. Perrin, J. Chotard, F. Denis, N. 'doye et al., Cross-sectional and longitudinal epidemiology of hepatitis B in Senegal, Prog Med Virol, vol.27, pp.148-162, 1981.

J. F. Botha, G. M. Dusheiko, M. Ritchie, H. Mouton, and M. C. Kew, Hepatitis B virus carrier state in Black children in Ovamboland: Role of perinatal and horizontal infection, Lancet, vol.323, pp.1210-1212, 1984.

M. E. Mendy, S. J. Mcconkey, M. Van-der-sande, S. Crozier, S. Kaye et al., Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia, Virol J, vol.5, p.49, 2008.

R. P. Beasley, Hepatitis B virus as the etiologic agent in hepatocellular carcinoma -epidemiologic considerations, Hepatology, vol.1982, pp.21-26

M. Kojima, M. Yasuda, H. Tanaka, and N. Adachi, MS: Natural seroconversion of HBe antigen to anti-HBe in HBs antigen carrier children-From the difference of the modes of HBV transmission

, Acta Hepatol Jpn, vol.26, pp.1139-1145, 1985.

M. H. Chang, J. L. Sung, C. Y. Lee, C. J. Chen, J. S. Chen et al., Factors affecting clearance of hepatitis B e antigen in hepatitis B surface antigen carrier children, J Pediatr, vol.115, pp.385-390, 1989.

S. M. Wheeley, M. J. Tarlow, and E. H. Boxall, Chronic hepatitis B in male and female children of HBsAg carrier mothers, J Hepatol, vol.8, pp.226-231, 1989.

N. Hopkirk, C. D. Moyes, and C. R. Lucas, Liver function and hepatitis markers in carriers of hepatitis B virus in New Zealand, N Z Med J, vol.113, pp.114-116, 2000.

A. Soderstrom, G. Norkrans, N. Conradi, M. Krantz, P. Horal et al., Histologic activity of childhood chronic hepatitis B related to viremia levels, genotypes, mutations, and epidemiologic factors, J Pediatr Gastroenterol Nutr, vol.35, pp.487-494, 2002.

R. W. Ryder, H. C. Whittle, A. B. Sanneh, A. B. Ajdukiewicz, S. Tulloch et al., Persistent hepatitis B virus infection and hepatoma in The Gambia, west Africa. A case-control study of 140 adults and their 603 family contacts, Am J Epidemiol, vol.136, pp.1122-1131, 1992.

C. C. Hsieh, A. Tzonou, X. Zavitsanos, E. Kaklamani, S. J. Lan et al., Age at first establishment of chronic hepatitis B virus infection and hepatocellular carcinoma risk: A birth order study, Am J Epidemiol, vol.136, pp.1115-1121, 1992.

C. Chu, M. Hussain, and A. Lok, Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C, Gastroenterology, vol.122, pp.1756-1762, 2002.

U. Dumpis, M. Mendy, A. Hill, M. Thursz, A. Hall et al., Prevalence of HBV core promoter/precore/core mutations in Gambian chronic carriers, J Med Virol, vol.65, pp.664-670, 2001.

S. Villar, L. Roux-goglin, E. Gouas, D. A. Plymoth, A. Ferro et al., Seasonal variation in TP53 R249S-mutated serum DNA with aflatoxin exposure and hepatitis B virus infection, Environ Health Perspect, vol.119, pp.1635-1640, 2011.

D. A. Gouas, S. Villar, S. Ortiz-cuaran, P. Legros, G. Ferro et al., P: TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia, Carcinogenesis, vol.33, pp.1219-1224, 2012.

A. Kramvis and M. C. Kew, Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes, Hepatol Res, vol.37, pp.9-19, 2007.

C. M. Olinger, V. Venard, M. Njayou, A. Oyefolu, I. Maïga et al., Phylogenetic analysis of the precore/core gene of hepatitis B virus genotypes E and A in West Africa: new subtypes, mixed infections and recombinations, J Gen Virol, vol.87, pp.1163-1173, 2006.

M. Mendy, I. Peterson, S. Hossin, T. Peto, M. L. Jobarteh et al., Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster dose, PLoS One, vol.8, p.58029, 2013.

Y. Ni, M. Chang, J. Wu, H. Hsu, H. Chen et al., Minimization of hepatitis B infection by a 25-year universal vaccination program, J Hepatol, vol.57, pp.730-735, 2012.

H. Chen, L. Lin, F. Hu, J. Lee, W. Lin et al., Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV, Gastroenterology, vol.142, pp.773-781, 2012.

D. Chen, Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B, J Hepatol, vol.50, pp.805-816, 2009.

F. Cui, H. Luo, F. Wang, H. Zheng, X. Gong et al., Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: Results from China GAVI project final evaluation, Vaccine, vol.2013, pp.36-42

A. Kramvis and C. J. Clements, Implementing a birth dose of hepatitis B vaccine for home deliveries in Africa-Too soon? Vaccine, vol.28, pp.6408-6410, 2010.

, WHO: Global routine vaccination coverage, Wkly Epidemiol Rec, vol.88, pp.482-486, 2012.

, The Gambia Hepatitis Study Group: Hepatitis B vaccine in the Expanded Programme of Immunisation: the Gambian experience, Lancet, vol.1, pp.1057-1060, 1989.

H. I. Yang, S. N. Lu, Y. F. Liaw, S. L. You, C. A. Sun et al., Hepatitis B e antigen and the risk of hepatocellular carcinoma, N Engl J Med, vol.347, pp.168-174, 2002.

, WHO: Hepatitis B vaccines. WHO position paper, Wkly Epidemiol Rec, vol.84, pp.405-420, 2009.